Stay updated on HER2+ Breast Cancer Adjuvant Trial
Sign up to get notified when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.

Latest updates to the HER2+ Breast Cancer Adjuvant Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA minor website update was applied: Revision: v3.4.2 was added, and older notices including a government funding lapse message and Revision: v3.4.1 were removed. This change does not affect the study data, eligibility criteria, outcomes, or trial status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about government funding delays and NIH operating status was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' timestamp, and updated the page to show 'Revision: v3.4.0'. The older variant labels for QC criteria, FEAR Act data, and revision information were standardized or removed.SummaryDifference0.2%

- Check35 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No substantive changes to study details, eligibility criteria, or user interactions are evident.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page footer now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page footer.SummaryDifference0.1%

Stay in the know with updates to HER2+ Breast Cancer Adjuvant Trial
Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.